Universal Registration Document Including The Annual Financial Report

Overview

The report describes the company as a clinical-stage developer of minimally invasive medical devices, with Artus, Kalios, Epygon and Kardiozis forming its core portfolio. In 2021, the company obtained authorisations for Minerva and Dry Artus studies, advanced Kalios clinical work, and completed a June IPO. The report also records a year-end Group workforce of 50 employees, while consolidated revenue remained nil as the products had not yet reached commercial launch.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Publication date: 29 April 2022
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services